4.8 Article

NADPH Selective Depletion Nanomedicine-Mediated Radio-Immunometabolism Regulation for Strengthening Anti-PDL1 Therapy against TNBC

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

High-Z-Sensitized Radiotherapy Synergizes with the Intervention of the Pentose Phosphate Pathway for In Situ Tumor Vaccination

Yuxiang Wang et al.

Summary: In situ tumor vaccination is achieved through the integration of Phy@PLGdH nanosheets, which enhances radiation therapy-induced immunogenic cell death. The nanosheets exhibit improved radiosensitization and tumor penetrability, while Phy-mediated PPP intervention amplifies the oxidative stress and DNA damage caused by PLGdH-sensitized radiation therapy. This results in effective immunogenic cell death and enhanced immunogenicity of irradiated tumor cells. Furthermore, Phy@PLGdH-sensitized radiation therapy successfully triggers a robust CD8(+)-T-cell-dependent antitumor immune response, which enhances checkpoint blockade immunotherapies against primary and metastatic tumors.

ADVANCED MATERIALS (2022)

Review Oncology

Determining PD-L1 Status in Patients With Triple-Negative Breast Cancer: Lessons Learned From IMpassion130

Sunil S. Badve et al.

Summary: Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer. Increased tumor-infiltrating lymphocyte counts have been found to be prognostic for survival in TNBC. Anti-PD-L1 and anti-PD-1 antibodies have been approved for the treatment of TNBC, and PD-L1 testing is becoming increasingly important in guiding treatment options.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

Article Oncology

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

Fernanda G. Herrera et al.

Summary: Developing strategies to inflame tumors is critical for increasing response to immunotherapy. Low-dose radiation reprograms the tumor microenvironment to promote T-cell infiltration and, when combined with immunotherapy, simultaneously mobilizes innate and adaptive immunity, predominantly CD4(+) effector T cells, for tumor control dependent on NKG2D. This combination induces important responses in patients with metastatic immune-cold tumors.

CANCER DISCOVERY (2022)

Article Multidisciplinary Sciences

Polypeptide nanoformulation-induced immunogenic cell death and remission of immunosuppression for enhanced chemoimmunotherapy

Xiangru Feng et al.

Summary: Conventional chemotherapeutics induce immunogenic cell death in tumor cells, but are limited by the presence of immunosuppressive lymphocytes in the tumor microenvironment. Combining low-dose DOX with 1MT to overcome immune suppression, delivered via a reduction-responsive polypeptide nanogel, effectively suppressed tumor growth and enhanced CD8(+) T cell frequency. The chemoimmunotherapy strategy shows great potential in clinical cancer therapy.

SCIENCE BULLETIN (2021)

Editorial Material Pharmacology & Pharmacy

Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy

Yajie Sun et al.

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Article Chemistry, Multidisciplinary

An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer

Lili Wang et al.

Summary: The Ir1 iridium complex induces immunogenic cell death in non-small cell lung cancer cells, triggering an anti-tumor T-cell response and resulting in long-lasting anti-tumor immunity through the activation of ICD. Ir1 is the first Ir-based complex capable of developing an immunomodulatory response by inducing immunogenic cell death.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Engineering, Biomedical

Development of D-melittin polymeric nanoparticles for anti-cancer treatment

Shixian Lv et al.

Summary: Melittin, the primary peptide component in bee venom, has anti-tumor activity but its practical application is hindered by hemolytic activity and instability. Use of D-amino acids in place of L-amino acids reduces immunogenicity of melittin, allowing for safer delivery and maintaining cytolytic potential. D-melittin micelles show cytotoxicity in a pH-dependent manner, inducing immunogenic cell death and demonstrating potential for cancer immunotherapy. The study presents a new strategy for systemic delivery of cytotoxic peptides in cancer treatment.

BIOMATERIALS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Multidisciplinary Sciences

Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy

Eric H. Bent et al.

Summary: In a mouse model of BCR-ABL(+) B-cell acute lymphoblastic leukemia, chemotherapy-induced anti-cancer immunity is suppressed by the tumor microenvironment through production of cytokine IL-6. IL-6 inhibits the efficacy of immunotherapy and promotes resistance to doxorubicin, impacting CD8(+) T-cell-mediated anti-cancer responses.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Theranostic near-infrared-IIb emitting nanoprobes for promoting immunogenic radiotherapy and abscopal effects against cancer metastasis

Hao Li et al.

Summary: A nanoprobe based on NIR-IIb emitting quantum dots was designed to alleviate hypoxia in the tumor microenvironment, enhancing precision and efficacy of radiotherapy, and promoting anti-tumor immune responses.

NATURE COMMUNICATIONS (2021)

Article Chemistry, Multidisciplinary

Zoledronic Acid-Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment

Zhusheng Huang et al.

Summary: The self-assembled carrier-free coordination polymer nanorods can enhance reactive oxygen species production and induce cell death while depleting tumor-associated macrophages, improving the tumor microenvironment and boosting immune responses to enhance the efficacy of immunotherapy against tumors.

ACS NANO (2021)

Article Chemistry, Multidisciplinary

Genetically Encoding Light-Responsive Protein-Polymers Using Translation Machinery for the Multi-Site Incorporation of Photo-Switchable Unnatural Amino Acids

Bar Israeli et al.

Summary: This study demonstrates the successful incorporation of multiple light-responsive uAAs in elastin-like polypeptides, enabling reversible phase transitions and the creation of self-assembled nanostructures. The evolved translation machinery can be used for the design of other families of protein-based biomaterials with customized and tunable light-responsive behavior.

ADVANCED FUNCTIONAL MATERIALS (2021)

Article Oncology

Advances in Combining Radiation and Immunotherapy in Breast Cancer

Anthony T. Nguyen et al.

Summary: Breast irradiation has the potential to induce antitumor immune responses, and when combined with immune checkpoint blockade, it shows synergy in clinical settings. This has sparked substantial interest in combining radiation and immunotherapy to enhance immune responses for the treatment of breast cancer.

CLINICAL BREAST CANCER (2021)

Article Chemistry, Multidisciplinary

Noncanonical Amino Acids for Hypoxia-Responsive Peptide Self-Assembly and Fluorescence

Binbin Hu et al.

Summary: The design of endogenous stimuli-responsive amino acids allows for precise modulation of proteins or peptides under a biological microenvironment, as demonstrated in the development of efficient hypoxia imaging probes using a noncanonical amino acid. The unique properties of the synthesized amino acid facilitate the creation of aromatic peptides undergoing NTR-responsive self-assembly, leading to the development of morphology-transformable supramolecular probes for imaging hypoxic tumor cells. This versatile amino acid provides a powerful toolkit for synthetic biology and the creation of novel biomaterials responsive to biological environments.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Review Oncology

Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy

Wenxiang Zhang et al.

Summary: Tumor immune escape refers to tumor cells evading immune recognition and attack through immune checkpoint protein expression imbalance. Immune checkpoint inhibitors can restore immune response, making significant progress in breast cancer immunotherapy.

FRONTIERS IN ONCOLOGY (2021)

Article Engineering, Biomedical

Immunogenic-cell-killing and immunosuppression-inhibiting nanomedicine

Ying Wang et al.

Summary: The new polymer-based intelligent platform enables simultaneous delivery of paclitaxel and curcumin, targeting tumor cells for drug release and inducing immunogenic cell death, ultimately suppressing tumor growth and metastasis.

BIOACTIVE MATERIALS (2021)

Article Medicine, General & Internal

Pembrolizumab for Early Triple-Negative Breast Cancer

Peter Schmid et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Oncology

Role of Immunotherapy in Triple-Negative Breast Cancer

Tanya E. Keenan et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)

Review Multidisciplinary Sciences

Revisiting the PD-1 pathway

Nikolaos Patsoukis et al.

SCIENCE ADVANCES (2020)

Review Oncology

Metabolism of immune cells in cancer

Robert D. Leone et al.

NATURE REVIEWS CANCER (2020)

Review Oncology

Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy

Maxim Shevtsov et al.

FRONTIERS IN ONCOLOGY (2019)

Editorial Material Oncology

Immune-checkpoint inhibition for metastatic triple-negative breast cancer: safety first?

Nina D'Abreo et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Review Immunology

Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment

Hari Menon et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Biochemistry & Molecular Biology

Understanding the tumor immune microenvironment (TIME) for effective therapy

Mikhail Binnewies et al.

NATURE MEDICINE (2018)

Review Immunology

Macrophage Immunometabolism: Where Are We (Going)?

Jan Van den Bossche et al.

TRENDS IN IMMUNOLOGY (2017)

Article Multidisciplinary Sciences

DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells

Hiro Sato et al.

NATURE COMMUNICATIONS (2017)

Review Immunology

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy

Nisha Nagarsheth et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Article Biochemistry & Molecular Biology

NADPH Oxidases Are Essential for Macrophage Differentiation

Qing Xu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Review Cell Biology

Metabolomics: beyond biomarkers and towards mechanisms

Caroline H. Johnson et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)

Article Nanoscience & Nanotechnology

Analysis of nanoparticle delivery to tumours

Stefan Wilhelm et al.

NATURE REVIEWS MATERIALS (2016)

Review Oncology

Radioimmunotherapy of human tumours

Steven M. Larson et al.

NATURE REVIEWS CANCER (2015)

Review Multidisciplinary Sciences

Metabolism of stromal and immune cells in health and disease

Bart Ghesquiere et al.

NATURE (2014)

Article Oncology

PD-L1 Expression in Triple-Negative Breast Cancer

Elizabeth A. Mittendorf et al.

CANCER IMMUNOLOGY RESEARCH (2014)

Review Oncology

Clinical radioimmunotherapy-the role of radiobiology

Jean-Pierre Pouget et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2011)